Form 4: Cardlytics Director Converts RSUs to Common Stock

Cardlytics Director Srishti A. Gupta acquired 6,148 shares of common stock through the vesting and conversion of restricted stock units on October 30, 2025.

Summary

• Srishti A. Gupta, a Director of Cardlytics, Inc. [CDLX], reported a transaction on October 30, 2025.
• The transaction involved the conversion of 6,148 Restricted Stock Units (RSUs) into 6,148 shares of Cardlytics common stock.
• Each RSU represents a contingent right to receive one share of common stock or its cash equivalent at the Issuer's election.
• The RSU award, granted on October 30, 2024, vested in full on its one-year anniversary.
• Following this transaction, Srishti A. Gupta directly beneficially owns 6,148 shares of Cardlytics common stock.

Sentiment

Score: 5

Explanation: The filing reports a routine insider transaction (vesting and conversion of RSUs) which is neutral in sentiment. It reflects standard equity compensation practices and does not indicate significant positive or negative operational or financial news.

Positives

• Increased direct ownership of common stock by a company director, aligning their interests with shareholders.

Negatives

• No negative aspects are directly indicated by this routine insider transaction report.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

This Form 4 filing reports a routine insider transaction related to equity compensation. The vesting and conversion of Restricted Stock Units (RSUs) into common stock is a common practice for directors and executives, reflecting the fulfillment of long-term incentive plans. It indicates that the director's compensation structure includes equity-based awards, a standard in many publicly traded companies to align management interests with shareholder value.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may be viewed positively as it aligns the director's interests with shareholder value.
• Employees: This transaction is part of a standard equity compensation plan, which is a common component of employee and director remuneration.

Key Dates

Keywords

Cardlytics, CDLX, Srishti A. Gupta, Director, Insider Transaction, Form 4, Restricted Stock Units, RSU, Common Stock, Equity Compensation, Vesting